Stock of the Week: Precigen (PGEN)

Our Stock of the Week is Precigen (PGEN), which makes PAPZIMEOS, a gene therapy approved a year ago as the first treatment for recurrent respiratory papillomatosis. HPV causes growths to keep returning in the airway, and until last August the only option was surgery,...

Stock of the Week: Definium Therapeutics (DFTX)

Our Stock of the Week is Definium Therapeutics (DFTX). It was our Stock of the Week back on June 15, but as a reminder, Definium Therapeutics is a late-stage clinical biopharmaceutical company whose lead candidate is a pharmaceutically optimized form of LSD (DT120,...

Stock of the Week is Hewlett Packard Enterprise (HPE)

Our Stock of the Week is Hewlett Packard Enterprise (HPE). HPE has transformed itself from a slow-growth legacy hardware company into a major player in enterprise data center and computing infrastructure, positioning itself as an “edge-to-cloud hybrid infrastructure”...

Stock of the Week: Candel Therapeutics (CADL)

Our Stock of the Week is Candel Therapeutics (CADL). Candel is a clinical-stage biopharmaceutical company developing off-the-shelf immunotherapies for cancer, with its lead candidate aglatimagene besadenovec (CAN-2409) which has already posted positive Phase 3 results...

Stock of the Week: Five9, Inc. (FIVN)

Our Stock of the Week is Five9, Inc. (FIVN). Five9 is a cloud-based contact center software company that provides AI-powered customer experience solutions to enterprises, enabling businesses to handle customer interactions across voice, chat, email, and social...